171 related articles for article (PubMed ID: 37492573)
1. Differentiation in TCM patterns of chronic obstructive pulmonary disease by comprehensive metabolomic and lipidomic characterization.
Li J; Liu X; Shi Y; Xie Y; Yang J; Du Y; Zhang A; Wu J
Front Immunol; 2023; 14():1208480. PubMed ID: 37492573
[TBL] [Abstract][Full Text] [Related]
2. High-coverage lipidomics analysis reveals biomarkers for diagnosis of acute exacerbation of chronic obstructive pulmonary disease.
Liu X; Zhang H; Si Y; Du Y; Wu J; Li J
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Jun; 1201-1202():123278. PubMed ID: 35561641
[TBL] [Abstract][Full Text] [Related]
3. An integrated metabo-lipidomics profile of induced sputum for the identification of novel biomarkers in the differential diagnosis of asthma and COPD.
Correnti S; Preianò M; Gamboni F; Stephenson D; Pelaia C; Pelaia G; Savino R; D'Alessandro A; Terracciano R
J Transl Med; 2024 Mar; 22(1):301. PubMed ID: 38521955
[TBL] [Abstract][Full Text] [Related]
4. Identification of lipid biomarker from serum in patients with chronic obstructive pulmonary disease.
Liu D; Meister M; Zhang S; Vong CI; Wang S; Fang R; Li L; Wang PG; Massion P; Ji X
Respir Res; 2020 Sep; 21(1):242. PubMed ID: 32957957
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics study on model rats of chronic obstructive pulmonary disease treated with Bu‑Fei Jian‑Pi.
Li J; Yang L; Li Y; Tian Y; Li S; Jiang S; Wang Y; Li X
Mol Med Rep; 2015 Feb; 11(2):1324-33. PubMed ID: 25370181
[TBL] [Abstract][Full Text] [Related]
6. [Serum metabolomics of chronic obstructive pulmonary disease with lung-Qi deficiency syndrome].
Duan F; Li MM; Li WX; Tang JF; Wang ZW
Zhongguo Zhong Yao Za Zhi; 2022 Apr; 47(8):2251-2256. PubMed ID: 35531742
[TBL] [Abstract][Full Text] [Related]
7. Serum metabolic profiling of traditional Chinese medicine syndromes in patients with diarrhea-predominant irritable bowel syndrome.
Tang SQ; Wang YL; Xie ZY; Zhang Y; Guo Y; Gao KL; Mao TY; Xie CE; Li JX; Gao XY
J Integr Med; 2021 May; 19(3):274-281. PubMed ID: 33775600
[TBL] [Abstract][Full Text] [Related]
8. Plasma Metabolomics and Lipidomics Reveal Perturbed Metabolites in Different Disease Stages of Chronic Obstructive Pulmonary Disease.
Zhou J; Li Q; Liu C; Pang R; Yin Y
Int J Chron Obstruct Pulmon Dis; 2020; 15():553-565. PubMed ID: 32210549
[TBL] [Abstract][Full Text] [Related]
9. Screening and identification of potential biomarkers and establishment of the diagnostic serum proteomic model for the Traditional Chinese Medicine Syndromes of tuberculosis.
Liu J; Li Y; Wei L; Yang X; Xie Z; Jiang T; Wang C; Zhang X; Xu D; Chen Z; Yang F; Li JC
J Ethnopharmacol; 2014 Sep; 155(2):1322-31. PubMed ID: 25072359
[TBL] [Abstract][Full Text] [Related]
10. A urine and serum metabolomics study of gastroesophageal reflux disease in TCM syndrome differentiation using UPLC-Q-TOF/MS.
Ye X; Wang X; Wang Y; Sun W; Chen Y; Wang D; Li Z; Li Z
J Pharm Biomed Anal; 2021 Nov; 206():114369. PubMed ID: 34551376
[TBL] [Abstract][Full Text] [Related]
11. Efficiency and Safety of Baofei Granules in Chronic Obstructive Pulmonary Disease (Lung and Spleen Qi Deficiency Syndrome): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial.
Sun Y; Chen X; Zhang L; Yuan WA; Chen Q; Zhang YB; Liu LJ; Zhang W; Sun M
Drug Des Devel Ther; 2022; 16():4251-4267. PubMed ID: 36540716
[TBL] [Abstract][Full Text] [Related]
12. [Plasma metabonomic studies on the stable phase chronic obstructive pulmonary disease patients of Fei-qi deficiency syndrome and the Chinese materia medica intervention].
Liu ZG; Li ZG; Peng B
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Dec; 31(12):1619-26. PubMed ID: 22384547
[TBL] [Abstract][Full Text] [Related]
13. The effective evaluation on symptoms and quality of life of chronic obstructive pulmonary disease patients treated by comprehensive therapy based on traditional Chinese medicine patterns.
Li JS; Li SY; Xie Y; Yu XQ; Wang MH; Sun ZK; Ma LJ; Jia XH; Zhang HL; Xu JP; Hou CX
Complement Ther Med; 2013 Dec; 21(6):595-602. PubMed ID: 24280466
[TBL] [Abstract][Full Text] [Related]
14. Recent Progress on Mass Spectrum Based Approaches for Absorption, Distribution, Metabolism, and Excretion Characterization of Traditional Chinese Medicine.
Bai X; Zhu C; Chen J; Jiang X; Jin Y; Shen R; Zhu M; Wu C
Curr Drug Metab; 2022; 23(2):99-112. PubMed ID: 35152864
[TBL] [Abstract][Full Text] [Related]
15. Exploring the "gene-protein-metabolite" network of coronary heart disease with phlegm and blood stasis syndrome by integrated multi-omics strategy.
Yang G; Zhou S; He H; Shen Z; Liu Y; Hu J; Wang J
Front Pharmacol; 2022; 13():1022627. PubMed ID: 36523490
[No Abstract] [Full Text] [Related]
16. Urinary metabolomic profiling reveals difference between two traditional Chinese medicine subtypes of coronary heart disease.
Guo N; Chen Y; Yang X; Yan H; Fan B; Quan J; Wang M; Yang H
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1179():122808. PubMed ID: 34218095
[TBL] [Abstract][Full Text] [Related]
17. Study of the metabolomic relationship between lung cancer and chronic obstructive pulmonary disease based on direct infusion mass spectrometry.
Callejón-Leblic B; Pereira-Vega A; Vázquez-Gandullo E; Sánchez-Ramos JL; Gómez-Ariza JL; García-Barrera T
Biochimie; 2019 Feb; 157():111-122. PubMed ID: 30439409
[TBL] [Abstract][Full Text] [Related]
18. Metabolomic Profiling Differences among Asthma, COPD, and Healthy Subjects: A LC-MS-based Metabolomic Analysis.
Liang Y; Gai XY; Chang C; Zhang X; Wang J; Li TT
Biomed Environ Sci; 2019 Sep; 32(9):659-672. PubMed ID: 31635682
[TBL] [Abstract][Full Text] [Related]
19. Effect of sequential treatment with TCM syndrome differentiation on acute exacerbation of chronic obstructive pulmonary disease and AECOPD risk window.
Jiansheng L; Haifeng W; Suyun L; Hailong Z; Xueqing Y; Xiaoyun Z; Fengsen L; Xianmei Z; Zikai S; Yimin M; Lijun M; Yijie Z; Guojun Z; Bingxiang T
Complement Ther Med; 2016 Dec; 29():109-115. PubMed ID: 27912934
[TBL] [Abstract][Full Text] [Related]
20. [Clinical practice guideline for stable chronic obstructive pulmonary disease with traditional Chinese medicine (draft version for comments)].
Chang-Zheng F; Qing M; Mao-Rong F; Xing L; Qiong Z; Yi-Ling F; Qiu-Xiao MA; Qing C; Ning W; Ya-Ni H
Zhongguo Zhong Yao Za Zhi; 2020 Nov; 45(22):5309-5322. PubMed ID: 33350190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
